TScan Therapeutics Announces Partnership with QIAGEN to Develop T Cell-Based Laboratory Test for Comprehensive COVID-19 Immune ResponseBusiness Wire • 11/10/20
QIAGEN N.V. to hold investor call on Wednesday, October 28, after releasing results for Q3 2020 and first nine months of 2020Business Wire • 10/27/20
QIAGEN Reports Strong Results for Third Quarter and First Nine Months of 2020 and Increases Outlook for Full-Year 2020Business Wire • 10/27/20
Coronavirus Drives Testing Stocks: Is There Room for More Upside?Zacks Investment Research • 10/06/20
QIAGEN to Complement COVID-19 Testing Portfolio With Novel Kit That Simplifies and Accelerates PCR Analysis for Research ApplicationsBusiness Wire • 10/05/20
The FDA Just Ranked Coronavirus Tests by Sensitivity. Here's What That MeansThe Motley Fool • 10/03/20
Is QIAGEN N.V. (QGEN) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 09/22/20
QIAGEN fully acquires NeuMoDx Molecular, Inc., rounding out portfolio of PCR-based diagnostic automation systemsBusiness Wire • 09/17/20
Qiagen to launch rapid coronavirus test it says could be used in airports and stadiumsCNBC • 09/08/20
QIAGEN to Launch Rapid Portable Test That Can Analyze Over 30 Samples Per Hour for SARS-CoV-2 AntigenBusiness Wire • 09/08/20
QIAGEN to Launch Easy-to-Use Digital Test in the U.S. for Rapid Detection of SARS-CoV-2 Antibodies Following FDA Emergency Use AuthorizationBusiness Wire • 08/24/20